PURPOSE: Our objectives were to describe recent trends in the characteristics and in-hospital outcomes in diabetic as compared with non-diabetic patients hospitalized with ST-segment elevation myocardial infarction (STEMI). METHODS: We reviewed the medical records of 2537 persons with (n = 684) and without (n = 1853) a history of diabetes who were hospitalized for STEMI between 1997 and 2009 at 11 medical centres in Central Massachusetts. RESULTS: Diabetic patients were more likely to be older, female and to have a higher prevalence of previously diagnosed comorbidities. Diabetic patients were more likely to have developed important in-hospital complications and to have a longer hospital stay compared with non-diabetic patients. Between 1997 and 2009, there was a marked decline in hospital mortality in diabetic (20.0%-5.6%) and non-diabetic (18.6%-7.5%) patients. CONCLUSION: Despite reduced hospital mortality in patients hospitalized with STEMI, diabetic patients continue to experience significantly more adverse outcomes than non-diabetics.
PURPOSE: Our objectives were to describe recent trends in the characteristics and in-hospital outcomes in diabetic as compared with non-diabeticpatients hospitalized with ST-segment elevation myocardial infarction (STEMI). METHODS: We reviewed the medical records of 2537 persons with (n = 684) and without (n = 1853) a history of diabetes who were hospitalized for STEMI between 1997 and 2009 at 11 medical centres in Central Massachusetts. RESULTS:Diabeticpatients were more likely to be older, female and to have a higher prevalence of previously diagnosed comorbidities. Diabeticpatients were more likely to have developed important in-hospital complications and to have a longer hospital stay compared with non-diabeticpatients. Between 1997 and 2009, there was a marked decline in hospital mortality in diabetic (20.0%-5.6%) and non-diabetic (18.6%-7.5%) patients. CONCLUSION: Despite reduced hospital mortality in patients hospitalized with STEMI, diabeticpatients continue to experience significantly more adverse outcomes than non-diabetics.
Authors: Kim A Eagle; Shaun G Goodman; Alvaro Avezum; Andrzej Budaj; Cynthia M Sullivan; José López-Sendón Journal: Lancet Date: 2002-02-02 Impact factor: 79.321
Authors: R J van der Schaaf; J P S Henriques; J J Wiersma; K T Koch; J Baan; K J J Mulder; J D Durrer; J G P Tijssen; J J Piek; R J de Winter Journal: Heart Date: 2005-05-12 Impact factor: 5.994
Authors: Kim A Eagle; Brahmajee K Nallamothu; Rajendra H Mehta; Christopher B Granger; Philippe Gabriel Steg; Frans Van de Werf; Jose López-Sendón; Shaun G Goodman; Ann Quill; Keith A A Fox Journal: Eur Heart J Date: 2008-03 Impact factor: 29.983
Authors: A K Berger; J A Breall; B J Gersh; A E Johnson; W J Oetgen; T A Marciniak; K A Schulman Journal: Am J Cardiol Date: 2001-02-01 Impact factor: 2.778
Authors: E Braunwald; E M Antman; J W Beasley; R M Califf; M D Cheitlin; J S Hochman; R H Jones; D Kereiakes; J Kupersmith; T N Levin; C J Pepine; J W Schaeffer; E E Smith; D E Steward; P Theroux; J S Alpert; K A Eagle; D P Faxon; V Fuster; T J Gardner; G Gregoratos; R O Russell; S C Smith Journal: J Am Coll Cardiol Date: 2000-09 Impact factor: 24.094
Authors: Robert J Goldberg; Daniel G Kramer; Darleen Lessard; Jorge Yarzebski; Joel M Gore Journal: Coron Artery Dis Date: 2007-03 Impact factor: 1.439
Authors: Jane S Saczynski; Frederick A Spencer; Joel M Gore; Jerry H Gurwitz; Jorge Yarzebski; Darleen Lessard; Robert J Goldberg Journal: Arch Intern Med Date: 2008-10-27
Authors: Thiago Ovanessian Hueb; Eduardo Gomes Lima; Mauricio S Rocha; Sergio F Siqueira; Silvana Angelina Dório Nishioka; Giselle L Peixoto; Marcos M Saccab; Rosa Maria Rahmi Garcia; José Antonio F Ramires; Roberto Kalil Filho; Martino Martinelli Filho Journal: Medicine (Baltimore) Date: 2019-03 Impact factor: 1.889